SMTL ID : 8f60.1

anti-BTLA monoclonal antibody r23C8 in complex with BTLA

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.64 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN.1: 5 residues within 4Å: Chain C: N.80, G.81, S.82, T.100, Y.102 1 PLIP interactions: 1 interactions with chain C Hydrogen bonds: C:Y.102

1 x ACT: ACETATE ION(Non-functional Binders)

ACT.2: 5 residues within 4Å: Chain B: R.50, T.53 Chain C: E.15, H.16, H.17 5 PLIP interactions: 3 interactions with chain C, 2 interactions with chain B Hydrogen bonds: C:H.17 Water bridges: C:H.17, B:T.53 Salt bridges: C:H.17, B:R.50

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cheung, T.C. et al., Epitope topography of agonist antibodies to the checkpoint inhibitory receptor BTLA. Structure (2023)

Release Date

2023-05-24

Peptides

r23C8 Fab heavy chain: A
r23C8 Fab light chain: B
B- and T-lymphocyte attenuator: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

r23C8 Fab heavy chain

r23C8 Fab light chain

B- and T-lymphocyte attenuator